Cough Assist Devices Market Size By Product Type (Automatic Cough Assist Device, Manual Cough Assist Device), By Choice of Delivery (Face Mask, Mouthpiece, Adapter), By End-use (Hospitals, Home Care Settings), 2023 – 2032

Cough Assist Devices Market Size

Cough Assist Devices Market size was valued at over USD 205.1 million in 2022 and is anticipated to grow at a CAGR of over 7.2% between 2023 and 2032. Increasing patient preference towards homecare settings, technological advancements and rising prevalence of respiratory disorders are among the key factors driving the industry growth. The global population is aging, and older adults are more susceptible to respiratory conditions and muscle weakness. The elderly population often requires assistance in maintaining proper lung function and managing respiratory secretions. Cough assist devices offer a non-invasive and effective solution for airway clearance in these individuals, contributing to market expansion.
 

Further, cough assist devices provide a means for individuals to receive respiratory therapy at home, improving their quality of life and reducing healthcare costs associated with hospital visits. The convenience and comfort offered by home-based cough assist devices are driving market growth. Thus, such aforementioned factors are set to cumulatively drive the cough assist devices market growth in the foreseeable future.
 

A cough assist device, also known as a mechanical insufflator-exsufflator, is a medical device used to assist individuals with impaired cough function in clearing their airways and managing respiratory secretions. It is primarily used for people with conditions that affect the muscles involved in coughing, such as neuromuscular disorders, spinal cord injuries, or certain respiratory conditions.
 

Cough assist devices can be expensive, especially for individuals without insurance coverage or in regions with limited healthcare resources. The high cost of these devices can act as a barrier to adoption, limiting market growth, particularly in low-income or developing regions. Further, lack of awareness, proper training and education for patients and caregivers on the correct use of the devices can hinder their effectiveness and limit market growth. Additionally, maintenance and servicing of the devices in home settings may pose logistical challenges, potentially impacting their utilization.
 

COVID-19 Impact

The recent outbreak of COVID-19 had a mild impact on the cough assist devices market revenue in 2020. The pandemic disrupted global supply chains, affecting the manufacturing and distribution of medical devices, including cough assist devices. Restrictions on international trade, transportation challenges, and disruptions in component supply led to delays and shortages of these devices. Further, the pandemic has slowed down the market for cough assist devices. COVID-19 can cause severe respiratory symptoms, and healthcare facilities experienced a surge in patients requiring assistance in clearing airway secretions. Overall, while the COVID-19 pandemic presented challenges for the cough assist devices industry in terms of supply chain disruptions and increased demand, it also accelerated innovation and the adoption of remote care solutions. Thus, the decreased infection rate and surge in novel product launches for better treatment and care is set to further accelerate the industry expansion in the coming years.
 

Cough Assist Devices Market Trends

The rise in the prevalence of respiratory diseases testing has contributed considerably to the increased adoption of cough assist devices. Increasing patient pool of chronic obstructive pulmonary disease (COPD) and neuromuscular diseases is estimated to prove beneficial for industry growth. Neuromuscular disorders, such as muscular dystrophy, spinal muscular atrophy, and amyotrophic lateral sclerosis (ALS), can lead to weakened respiratory muscles and impaired cough function. Further, COPD is a progressive respiratory condition characterized by airflow limitation and breathing difficulties. For instance, as per the World Health Organization data, COPD caused around 3.23 million deaths and it was the third-leading cause of deaths globally. Thus, increasing patient population of COPD will surge the product adoption rate, thereby augmenting the market growth.
 

Cough Assist Devices Market Analysis

Based on product type, the cough assist devices market is bifurcated into automatic cough assist device and manual cough assist device. The automatic cough assist device segment accounted for major revenue share and was valued at around USD 124.6 million in 2022. The high market growth is primarily attributed to parameters such as improved effectiveness, monitoring and data recording capabilities, homecare suitability, and ease of use among others. Automatic cough assist devices offer a user-friendly and convenient solution for individuals with impaired cough function. Automatic cough assist devices often come with adjustable pressure settings and timing options. This allows healthcare professionals to tailor the device to the specific needs of each individual. Thus, owing to above-mentioned variables, the market is expected to record robust growth over the forecast period.
 

Based on choice of delivery, the cough assist devices market is segmented into face mask, mouthpiece, and adapter. The mouthpiece segment held a majority revenue share in 2022 and is anticipated to reach over USD 190.3 million by 2032. Mouthpiece cough assist devices are relatively simple and easy to use. They consist of a mouthpiece that the individual can comfortably hold in their mouth and breathe through during the therapy. This design allows for greater accessibility and independence, as it eliminates the need for a mask or external equipment. Moreover, improved patient comfort, portability, and better hygienic considerations among other factors will further fuel the product adoption rate. Thus, all the above-mentioned factors are expected to boost the market growth over the forecast period.
 

Based on end-use, the cough assist devices market is segmented into hospitals, home care settings, and others. The home care settings segment held a significant revenue share in 2022 and is anticipated to witness fastest growth to reach over USD 161.4 million in 2032. Preference for personalized care, improved quality of life, reduced risk of infections and cost-effectiveness are the key attributes propelling the homecare segmental growth. Homecare cough assist devices can be a cost-effective alternative to hospital-based care as they allow individuals to receive respiratory care in the comfort and familiarity of their own homes.
 

Additionally, homecare cough assist devices may eliminate the need for caregiver assistance, reducing caregiving costs. Furthermore, hospital settings can be potential sources of infections, including healthcare-associated respiratory infections. By using cough assist devices at home, individuals can minimize their exposure to pathogens and reduce the risk of acquiring infections.
 

U.S. cough assist devices market is expected to reach around USD 134.5 million by 2032. Shift towards home-based care, technological advancements, increasing prevalence of respiratory conditions and reimbursement and insurance coverage in the U.S. are prime factors expected to drive the market growth. Adequate reimbursement and insurance coverage for cough assist devices have played a significant role in their adoption. The aging population is more susceptible to respiratory conditions. The U.S. has recorded a rising prevalence of respiratory conditions such as chronic obstructive pulmonary disease (COPD), neuromuscular disorders, and spinal cord injuries. These conditions often result in impaired cough function and the need for airway clearance assistance, thereby, driving the demand for cough assist devices. Therefore, the afore-mentioned factors are estimated to augment the regional market growth during the analysis period.
 

Cough Assist Devices Market Share

Few of the leading players operating in the cough assist devices market include:

• Air Liquide Medical Systems
• United Hayek Industries Inc.
• Hill-Rom Holdings, Inc.
• Koninklijke Philips N.V.
• McKesson Medical-Surgical
• Dima Italia Srl
• Breas Medical Ltd 

. The key market players are involved in developments including collaboration, mergers, product launches, and acquisition, to further strengthen their revenue generating prospectus.
 

Cough Assist Devices Industry News:

• In November 2022, ABM Respiratory Care received a CE mark for its BiWaze Cough system. The system works with high frequency oscillation to combine assisted cough and lung expansion to remove mucus. This product launch will help the company to enhance their product portfolio and improve their business revenue.
   
• In July 2020, Hillrom Holdings, Inc. has launched the Synclara Cough System, a cough assist therapy. It is a noninvasive therapy to remove secretions in patients. This product launch is expected to aid the company to enhance their R&D capabilities and gain a technological advancement over its peers.
   

Cough assist devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) and volume (Units) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product Type

• Automatic Cough Assist Device
• Manual Cough Assist Device

By Choice of Delivery

• Face Mask
• Mouthpiece
• Adapter

By End-use

• Hospitals
• Home Care Settings
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Peru
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Israel
  • Iran